{'fraction_non_alphanumeric': 0.022341376228775692, 'fraction_numerical': 0.002680965147453083, 'mean_word_length': 5.436781609195402, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
A novel v-erb-B-transformed cell-line co-expressing lymphoid and myeloid surface-markers.

We have generated a novel hematopoietic cell line which co-expresses lymphoid and myeloid cell surface markers. This cell line, termed E6-2TH, was derived from thymus tissue of a mouse which developed leukemia following lethal irradiation and reconstitution with retrovirally infected bone marrow progenitor cells. Infection was effected with a recombinant murine retrovirus containing v-erb-B. The cells which grew out from the thymus tissue were initially dependent on WEHI-3B conditioned medium as a source of exogenous growth factor, but progressed in culture to become growth factor independent. Flow cytometric analysis using lineage-specific surface markers demonstrated that the initial growth factor dependent cells co-expressed myeloid and B lymphoid antigens, while the derived growth factor independent cells expressed only antigens specific to the B lymphoid lineage. This result indicates a mixed lymphoid/myeloid phenotype in this cell line and subsequent lineage specialisation during in vitro tumor progression.